Owlet, Inc. (OWLT) is a Medical - Devices company in the Healthcare sector, currently trading at $5.66. It has a SharesGrow Score of 50/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is OWLT = $20 (+253.4% upside).
Valuation: OWLT trades at a trailing Price-to-Earnings (P/E) of -73.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.88.
Financials: revenue is $106M, +19.3%/yr average growth. Net income is $42M (loss), growing at -37.9%/yr. Net profit margin is -39.6% (negative). Gross margin is 50.6% (+16.9 pp trend).
Balance sheet: total debt is $13M against $35M equity (Debt-to-Equity (D/E) ratio 0.37, conservative). Current ratio is 1.85 (strong liquidity). Debt-to-assets is 15.2%. Total assets: $86M.
Analyst outlook: 3 / 5 analysts rate OWLT as buy (60%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 94/100 (Pass), Growth 48/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 58/100 (Partial), Future 73/100 (Pass), Income 10/100 (Fail).
